Pacific Biosciences
(PACB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,765 | 22,794 | 24,778 | 20,080 | 33,629 |
| Marketable Securities | 55,213 | 64,539 | 77,692 | 71,451 | 48,641 |
| Receivables | 11,421 | 11,761 | 10,427 | 8,009 | 5,245 |
| Inventories | 15,634 | 16,473 | 14,201 | 12,162 | 10,955 |
| TOTAL | $109,011 | $122,467 | $138,055 | $119,053 | $110,541 |
| Non-Current Assets | |||||
| PPE Net | 14,560 | 14,003 | 11,188 | 9,093 | 8,548 |
| Other Non-Current Assets | 14,313 | 14,165 | 12,128 | 12,029 | 12,018 |
| TOTAL | $28,873 | $28,168 | $23,316 | $21,122 | $20,566 |
| Total Assets | $137,884 | $150,635 | $161,371 | $140,175 | $131,107 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,359 | 8,311 | 5,395 | 4,734 | 4,749 |
| Accrued Expenses | 16,604 | 16,482 | 16,329 | 12,201 | 15,551 |
| Other current liabilities | 1,681 | 742 | 1,422 | 1,444 | 241 |
| TOTAL | $33,774 | $32,106 | $33,813 | $32,010 | $38,178 |
| Non-Current Liabilities | |||||
| Long Term Debt | 16,106 | 15,794 | 15,496 | 15,216 | 14,948 |
| Deferred Revenues | 7,130 | 6,571 | 10,667 | 13,631 | 17,637 |
| Other Non-Current Liabilities | 2,020 | 1,823 | 1,796 | 2,013 | 1,986 |
| TOTAL | $19,442 | $19,849 | $19,489 | $19,389 | $19,389 |
| Total Liabilities | $53,216 | $51,955 | $53,302 | $51,399 | $57,567 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 92,725 | 92,647 | 91,875 | 87,169 | 85,731 |
| Common Shares | 93 | 93 | 91 | 87 | 80 |
| Retained earnings | -787,544 | -768,514 | -751,020 | -732,521 | -713,169 |
| Other shareholders' equity | 5 | 23 | 52 | 41 | -7 |
| TOTAL | $84,668 | $98,680 | $108,069 | $88,776 | $73,540 |
| Total Liabilities And Equity | $137,884 | $150,635 | $161,371 | $140,175 | $131,107 |